Hematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation, AutologousGraft vs Host DiseaseStem Cell TransplantationTransplantation ConditioningPeripheral Blood Stem Cell TransplantationHematopoietic Stem CellsStem CellsMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMelphalanTreatment OutcomeHematologic NeoplasmsCombined Modality TherapyBone Marrow TransplantationRemission InductionSalvage TherapyDisease-Free SurvivalRecurrenceCyclophosphamideHodgkin DiseaseMyeloablative AgonistsHematopoietic Stem Cell MobilizationEtoposideLymphoma, Non-HodgkinTransplantationRetrospective StudiesSurvival RateTissue DonorsAntigens, CD34Histocompatibility TestingCytarabineCarmustineGraft SurvivalWhole-Body IrradiationSurvival AnalysisStem Cell NicheTransplantation ChimeraBone Marrow PurgingThiotepaBusulfanFollow-Up StudiesVincristineCell DifferentiationAdult Stem CellsImmunosuppressive AgentsHematopoiesisHepatic Veno-Occlusive DiseaseImmunocompromised HostAmyloidosisPrognosisLymphoma, Mantle-CellLeukemiaEmbryonic Stem CellsBoronic AcidsMesenchymal Stem Cell TransplantationTime FactorsPyrazinesDexamethasoneDoxorubicinAntibodies, Monoclonal, Murine-DerivedLymphoma, FollicularAntineoplastic AgentsThalidomideGranulocyte Colony-Stimulating FactorKidney TransplantationAntineoplastic Agents, AlkylatingLymphoma, T-Cell, PeripheralBone MarrowBone Marrow CellsCord Blood Stem Cell TransplantationAutograftsLymphomaCell LineageLiver TransplantationLeukemia, Myeloid, AcuteLeukapheresisIfosfamideMice, Inbred C57BLFlow CytometryHLA AntigensAnemia, AplasticHistocompatibilityInduction ChemotherapyPluripotent Stem CellsCell TransplantationCells, CulturedPrednisonePancytopeniaNeoplasm, ResidualPodophyllotoxinCytomegalovirus InfectionsMyelodysplastic SyndromesLymphoma, Large B-Cell, DiffuseMesenchymal Stromal CellsMaintenance ChemotherapyProspective StudiesNeural Stem CellsFetal Blood